Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Clinical Laboratory, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Cancer Biomark. 2024;39(1):1-13. doi: 10.3233/CBM-220410.
Accumulating evidence indicates that circular RNAs (circRNAs) contribute to breast cancer (BC) development and progression. However, the role of circ_0058063 in BC and its underlying molecular processes remain unclear.
The expression of circ_0058063, miR-557, and DLGAP5 in BC tissues and cells was determined using real time quantitative PCR or western blotting. The functions of circ_0058063 in BC cells were detected using CCK-8, Transwell, caspase-3 activity, and xenograft tumor assays. The specific binding of circ_0058063/miR-557 and DLGAP5/miR-557 was verified using RNA immunoprecipitation (RIP) and dual-luciferase reporter assays.
circ_0058063 expression was upregulated in BC tissues and cells. circ_0058063 knockdown inhibited proliferation and migration but promoted apoptosis in MCF-7 and MDA-MB-231 cells in vitro. In vivo studies further validated that the knockdown of circ_0058063 repressed tumor growth. Mechanistically, circ_0058063 directly sponged miR-557 and negatively regulated its expression. Additionally, miR-557 inhibition reversed the tumor-suppressive effects of the circ_0058063 knockdown on the survival of MDA-MB-231 and MCF-7 cells. Moreover, miR-557 directly targeted DLGAP5. DLGAP5 knockdown suppressed MCF-7 and MDA-MB-231 cell growth, and these effects were reversed by miR-557 downregulation.
Our findings verify that circ_0058063 acts as a sponge for miR-557 to upregulate DLGAP5 expression. These findings suggest that the circ_0058063/miR-557/DLGAP5 axis is an important regulator of oncogenic function and may be a promising therapeutic target for BC.
越来越多的证据表明,环状 RNA(circRNAs)参与乳腺癌(BC)的发生和发展。然而,circ_0058063 在 BC 中的作用及其潜在的分子机制尚不清楚。
采用实时定量 PCR 或 Western blot 检测 BC 组织和细胞中 circ_0058063、miR-557 和 DLGAP5 的表达。通过 CCK-8、Transwell、caspase-3 活性和异种移植肿瘤实验检测 circ_0058063 在 BC 细胞中的功能。采用 RNA 免疫沉淀(RIP)和双荧光素酶报告基因实验验证 circ_0058063/miR-557 和 DLGAP5/miR-557 的特异性结合。
circ_0058063 在 BC 组织和细胞中表达上调。circ_0058063 敲低抑制 MCF-7 和 MDA-MB-231 细胞的增殖和迁移,但促进细胞凋亡。体内研究进一步证实,circ_0058063 的敲低抑制肿瘤生长。机制上,circ_0058063 可直接吸附 miR-557 并负调控其表达。此外,miR-557 抑制逆转了 circ_0058063 敲低对 MDA-MB-231 和 MCF-7 细胞存活的肿瘤抑制作用。此外,miR-557 可直接靶向 DLGAP5。DLGAP5 敲低抑制 MCF-7 和 MDA-MB-231 细胞生长,而 miR-557 下调则逆转了这些作用。
本研究证实 circ_0058063 作为 miR-557 的海绵上调 DLGAP5 表达。这些发现表明 circ_0058063/miR-557/DLGAP5 轴是致癌功能的重要调节剂,可能成为 BC 的有前途的治疗靶点。